<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Nanogen from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Nanogen news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 08:58:05 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Nanogen" rel="self" type="application/rss+xml" />

	
<item><title>Elitech Sells Nanogen Microarray Assets to Gamida for Life Group</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3999131&amp;HITNO=0&amp;MSIZE=7&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3999131&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2517330551%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3999131&amp;HITNO=0&amp;MSIZE=7&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3999131&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2517330551%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>GenomeWeb:</description></item>
<item><title>Elitech Sells Nanogen Microarray Assets to Dutch Healthcare Group</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3984106&amp;HITNO=1&amp;MSIZE=7&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3984106&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508017170%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3984106&amp;HITNO=1&amp;MSIZE=7&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3984106&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508017170%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>GenomeWeb:</description></item>
<item><title>Curtain Call: Perlegen Ceases Operations, Decision Biomarkers Files for Bankruptcy</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3889627&amp;HITNO=2&amp;MSIZE=7&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3889627&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2458838193%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3889627&amp;HITNO=2&amp;MSIZE=7&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3889627&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2458838193%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>GenomeWeb:</description></item>
<item><title>David L. Macdonald Appointed CEO of GeneLink BioSciences, Inc</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3848871&amp;HITNO=3&amp;MSIZE=7&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3848871&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2437711191%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3848871&amp;HITNO=3&amp;MSIZE=7&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3848871&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2437711191%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>David L. Macdonald Appointed CEO of GeneLink BioSciences, Inc</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3835862&amp;HITNO=4&amp;MSIZE=7&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3835862&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2428773436%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3835862&amp;HITNO=4&amp;MSIZE=7&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3835862&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2428773436%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Stockwatch:</description></item>
<item><title>David L. Macdonald Appointed CEO of GeneLink BioSciences, Inc</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3835854&amp;HITNO=5&amp;MSIZE=7&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3835854&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2428770598%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3835854&amp;HITNO=5&amp;MSIZE=7&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3835854&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2428770598%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PR Newswire via Yahoo!:</description></item>
<item><title>David L. Macdonald Appointed CEO of GeneLink BioSciences, Inc</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3835852&amp;HITNO=6&amp;MSIZE=7&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3835852&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2428770529%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3835852&amp;HITNO=6&amp;MSIZE=7&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Nanogen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3835852&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2428770529%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PR Newswire:</description></item>
</channel></rss>